Thigh muscle MRI in immune-mediated necrotising myopathy: Extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity

Annals of the Rheumatic Diseases

Volumn 76, Issue 4, 2017, Pages 681-687

  Pinal Fernandez, Iago ^a   Casal Dominguez, Maria ^b   Carrino, John A ^b   Lahouti, Arash H ^b   Basharat, Pari ^b   Albayda, Jemima ^b   Paik, Julie J ^b   Ahlawat, Shivani ^b   Danoff, Sonye K ^b   Lloyd, Thomas E ^b   Mammen, Andrew L ^a,b   Christopher Stine, Lisa ^b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Dermatomyositis; Magnetic Resonance Imaging; Polymyositis

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; SIGNAL RECOGNITION PARTICLE; ANTIBODY; HMGCR PROTEIN, HUMAN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE COURSE; DISEASE SEVERITY; FACE EDEMA; FEMALE; GLUTEUS MUSCLE; HUMAN; HUMAN TISSUE; IMMUNE MEDIATED NECROTISING MYOPATHY; INCLUSION BODY MYOSITIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE ATROPHY; MUSCLE EXAMINATION; MUSCLE INJURY; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; POPULATION RESEARCH; PREDICTIVE VALUE; PROTEIN FUNCTION; THIGH MUSCLE; AGED; ATROPHY; BLOOD; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; EDEMA; IMMUNOLOGY; MUSCLE DISEASE; NECROSIS; OBESITY; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE; THIGH;

ADIPOSITY; ADULT; AGED; ANTIBODIES; ATROPHY; BIOMARKERS; DERMATOMYOSITIS; EDEMA; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOSITIS, INCLUSION BODY; NECROSIS; POLYMYOSITIS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SIGNAL RECOGNITION PARTICLE; THIGH;

EID: 84988709983     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2016-210198     Document Type: Article

References (22)

1. Dalakas MC. Inflammatory muscle diseases. N Engl J Med 2015;373:393-4.
2. Del Grande F, Carrino JA, Del Grande M, et al. Magnetic resonance imaging of inflammatory myopathies. Top Magn Reson Imaging 2011;22:39-43.
3. Garcia J. MRI in inflammatory myopathies. Skeletal Radiol 2000;29:425-38.
4. Yoshida K, Kurosaka D, Joh K, et al. Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging. Arthritis Rheum 2010;62:3751-9.
5. Cox FM, Reijnierse M, Van Rijswijk CS, et al. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis. Rheumatology (Oxf ) 2011;50:1153-61.
6. Dion E, Cherin P, Payan C, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol 2002;29:1897-906.
7. Tasca G, Monforte M, De Fino C, et al. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis. Muscle Nerve 2015;52:956-62.
8. Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, the Netherlands. Neuromuscul Disord 2004;14:337-45.
9. Griggs RC, Askanas V, Dimauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
10. Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 2002;46:626-36.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
12. Mammen AL, Pak K, Williams EK, et al. Rarity of anti-3-hydroxy-3-methylglutarylcoenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res (Hoboken) 2012;64:269-72.
13. Valiyil R, Casciola-Rosen L, Hong G, et al. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: A case series. Arthritis Care Res (Hoboken) 2010;62:1328-34.
14. Kuo GP, Carrino JA. Skeletal muscle imaging and inflammatory myopathies. Curr Opin Rheumatol 2007;19:530-5.
15. Papke LE, Wooldridge JM. Econometric methods for fractional response variables With an application to 401(K) plan participation rates. J Appl Econ 1996;11:619-32.
16. Efron B, Tibshirani R. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
17. Yao L, Yip AL, Shrader JA, et al. Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies. Rheumatology (Oxf ) 2016;55:441-9.
18. Oconnell MJ, Powell T, Brennan D, et al. Whole-body MR imaging in the diagnosis of polymyositis. AJR Am J Roentgenol 2002;179:967-71.
19. Schulze M, Kotter I, Ernemann U, et al. MRI findings in inflammatory muscle diseases and their noninflammatory mimics. AJR Am J Roentgenol 2009;192: 1708-16.
20. Van De Vlekkert J, Maas M, Hoogendijk JE, et al. Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy. Muscle Nerve 2015;51:253-8.
21. Filli L, Maurer B, Manoliu A, et al. Whole-body MRI in adult inflammatory myopathies: do we need imaging of the trunk? Eur Radiol 2015;25: 3499-507.
22. Zheng Y, Liu L, Wang L, et al. Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle. Rheumatology (Oxf ) 2015;54:1017-24.